Side by Side

Compare

Read two to four stocks on the same scale — return, valuation and volatility in one table.

SelectedToday5Y Return

ALMSAlumis Inc− 2.29%− 16.54%
Partial Period · Jun 24, 2024 — Aug 31, 2026
JAGXJaguar Health Inc− 25.12%− 100.00%
GTBPGT Biopharma Inc+ 2.77%− 99.90%
ANVSAnnovis Bio Inc+ 2.17%− 96.06%

Four symbols is the limit; remove one to add another.

Period Return

Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.

ALMS− 16.5%JAGX− 100.0%GTBP− 99.9%ANVS− 96.1%Tap or hover the chart for values along the way

Metric	ALMSAlumis Inc	JAGXJaguar Health Inc	GTBPGT Biopharma Inc	ANVSAnnovis Bio Inc
Return
Last Price	11.10	0.52	0.26	1.41
Daily Change	− 2.29%	− 25.12%	+ 2.77%	+ 2.17%
Period ReturnPast 5 Years	− 16.54%Jun 24, 2024 — Aug 31, 2026	− 100.00%	− 99.90%	− 96.06%
Valuation
Market Cap	$1.42 B	$2.55 M	$11.5 M	$48.9 M
P/E Ratio	—	—	2.14	—
Dividend Yield	—	—	—	—
Net MarginTrailing 12M	6,114.6%	130.9%	26,209.5%	—
Risk
Beta	0.68	-0.24	0.85	1.30
52-Week Range	3.76 — $31.35	0.69 — $85.40	0.25 — $1.37	1.32 — $5.50
Company
Sector	—	—	—	—
Industry	Pharmaceuticals	Pharmaceuticals	Biotechnology	Biotechnology

Company

ALMSPharmaceuticals
JAGXPharmaceuticals
GTBPBiotechnology
ANVSBiotechnology

Alpaca · SIPUpdated 00:1415 Minutes Delayed

To Understand This

P/E and the Valuation RatiosYou can't tell whether a stock is cheap or expensive by looking at its price.Diversification: How Many Baskets Are Enough?Owning ten different stocks is not the same as owning ten different risks.